Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience
Benoit Imbeault1, Michel Vallée1
1Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.
Insights
Achieving adequate blood pressure control is key for preventing cardiovascular events. New guidelines recommend single-pill combinations for hypertension management to improve patient care and outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Effective blood pressure control is crucial for preventing cardiovascular events.
- Lifestyle modifications alone are often insufficient for adequate hypertension management.
- Pharmacologic therapy is necessary for most hypertensive patients.
Purpose of the Study:
- To review the evidence supporting the Hypertension Canada guidelines' recommendation for first-line treatment with single-pill combinations.
- To discuss how single-pill combinations can enhance patient care in hypertension management.
Main Methods:
- Review of current hypertension management guidelines, particularly the latest Hypertension Canada recommendations.
- Analysis of evidence supporting the shift from traditional monotherapy to initial single-pill combination therapy.
- Discussion of the benefits of single-pill combinations for patient adherence and outcomes.
Main Results:
- Traditional stepwise monotherapy is evolving towards initial single-pill combination therapy for hypertension.
- Single-pill combinations offer a simplified approach to pharmacologic management.
- Evidence suggests improved patient adherence and potentially better blood pressure control with combination therapy.
Conclusions:
- The shift towards first-line single-pill combinations in hypertension management is supported by evolving evidence.
- Single-pill combinations represent a significant advancement in optimizing pharmacologic therapy for hypertension.
- Implementing these combinations can lead to improved cardiovascular event prevention and patient care.
Abstract:
Adequate blood pressure control in patients with hypertension remains the pillar of cardiovascular-event prevention. Smoking cessation, reduced dietary salt intake, physical exercise and weight loss contribute to better blood pressure control and reduced cardiovascular morbidity, but alone, they are often insufficient in doing so, and their success is highly dependent on individual patient motivation. Pharmacologic therapy, thus, remains necessary for most patients, and our conception of the optimal way of approaching this therapy has evolved over the past decade. Traditionally, monotherapy using a first-line drug was initiated and uptitrated, with the addition of other antihypertensive agents as needed. The latest Hypertension Canada guidelines, however, now recommend first-line treatment with single-pill combinations in patients without compelling indications for treatment. In this review, we discuss the evidence behind this recommendation and how single-pill combinations can improve patient care.
More Related Videos
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
00:55Convenience Sampling Method
Convenience sampling is a non-random method of sample selection; this method selects individuals that are easily accessible and may result in biased data. For example, a marketing...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...